Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.
Clinical trial NCT05879276 · RECRUITING
Trial details
- NCT number
- NCT05879276
- Sponsor
- Central Hospital, Nancy, France
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-16
- Primary completion
- 2027-03-16
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.